FDA biosimilar guidance permits alternative drug delivery devices
The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.
The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.
The Council of Europe (CoE) has launched an online service which will allow patients to check the authenticity of their medication using just a smartphone.
US-based oncology services firm Biologics Inc will distribute a kidney cancer drugs being under a new contract with Pfizer.
Earnings at Catalent jumped in the second quarter as rising demand for its oral technologies offset weakness in sterile injectables.
Bend Research is on the lookout for more collaborative development alliances with Big Pharma through its spray-dried dispersion (SDD) technology.
BASi is looking at staffing levels to “sharply” cut costs after posting first quarter results a shareholder called “pitiful”.
Prismic Pharmaceuticals is hunting for alliances to help it bring a more efficient anti-psychotic to the market after acquiring assets from drug manufacturer Scarista.